Business Standard

Centre looking to phase out codeine-based cough syrups, select FDCs

The industry is divided on the issue of phasing out codeine-based cough syrups, which are used by many as intoxicants

cough syrup, medicine, cold
Premium

File photo of cough syrup | Photo: Shutterstock

Sohini Das Mumbai
The Centre has moved to phase out codeine-based cough syrups and some fixed-dose combination (FDC) drugs that are deemed ‘irrational’.

The fate of 19 FDCs and several codeine-based cough syrups is yet to be decided and the Drugs Technical Advisory Board (DTAB) is discussing the matter.

The industry is divided on the issue of phasing out codeine-based cough syrups, which are used by many as intoxicants.

Recently, the Narcotics Control Bureau (NCB) arrested a group for smuggling drugs between Uttar Pradesh and Mumbai. The NCB team recovered 13,248 bottles of codeine-based cough syrup weighing 1,600 kg from the gang.

Arvind

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Sep 26 2022 | 9:18 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com